Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection

Completed

• Conditions: Chronic Kidney Diseases; Hypertensive Heart Disease; Myocarditis; Diabetes Mellitus; Ischemic Heart Disease; Ischemic Stroke; Copd; Anemia; COVID-19; Chronic Heart Failure

• Registration Number: NCT05226416
• Lead Sponsor: Eurasian Association of Therapists

Brief Summary

Depersonalized multi-centered registry initiated to analyze dynamics of non-infectious diseases after SARS-CoV-2 infection in population of Eurasian adult patients.

Detailed Description

Assessment of hospital course and health status during 3, 6, 12 months after discharge in COVID-19 patients in cohorts with comorbidities and without comorbidities. Evaluation of comorbidity impact to severity of novel coronavirus disease and comorbidity impact to demand for medical care.

Study Timeline

• Study First Submitted: 2022-02-01
• Study First Submitted QC: 2022-02-04
• Study First Posted: 2022-02-07
• Study Start: 2022-02-21
• Primary Completion: 2022-03-31
• Study Completion: 2023-04-21
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-06
• Last Update Posted: 2023-05-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3554

Inclusion Criteria

• Suspected or confirmed COVID-19

Exclusion Criteria

• Age under 18 years.
• Refusal to be involved in study;

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
death for any cause	From date of hospitalization until the date of first documented date of death from any cause, assessed up to 12 months	rate of lethal outcomes
hospitalization for any cause	12 months after discharge	rate of hospitalization for any cause

Secondary Outcome Measures

Name	Time	Method
rate of demand for medical care	1 year after discharge	number of patients seeking for health care after discharge
onset of any disease diagnosed 1 year after discharge	1 year after discharge	rate of patients with onset of any disease diagnosed 1 year after discharge

Trial Locations

Locations (1)

Eurasian Association of Therapists; 🇷🇺 Moscow, Russian Federation